Utilize este identificador para referenciar este registo: http://hdl.handle.net/10071/13962
Registo completo
Campo DCValorIdioma
dc.contributor.authorBravo, A. M.-
dc.contributor.authorCrespo de Carvalho, J.-
dc.date.accessioned2017-07-12T11:19:57Z-
dc.date.available2017-07-12T11:19:57Z-
dc.date.issued2012-
dc.identifier.issn2167-7689por
dc.identifier.urihttps://ciencia.iscte-iul.pt/id/ci-pub-8607-
dc.identifier.urihttp://hdl.handle.net/10071/13962-
dc.description.abstractThe pharmaceutical industry is one of the firms where the search for quality is very close to compliance. Yet a major paradigm change is occurring in this industry due to the increase of returns and recalls. Hence, in this paper the authors combine the findings of previous literature reviews with a case study approach. Findings from previous literature reviews emerged from the links explored between pharmaceutical drugs quality, reverse logistics and sustainability. With the addition of a case study on a global manufacturing corporation in the area of generic drugs products one step further is introduced: understanding the type of returns companies receive, in particular from hospital pharmacies. With this approach authors are creating a link between two different parties: the application of a quality by design (QbD) risk management approach with the reduction of variability and risk of noncompliance, through the increase of knowledge and value into their products and processes.por
dc.language.isoengpor
dc.publisherOMICS Publishing Grouppor
dc.rightsopenAccesspor
dc.subjectSustainabilitypor
dc.subjectPharmaceutical industrypor
dc.subjectQuality by Design (QbD)por
dc.subjectValue addedpor
dc.subjectCase studypor
dc.titleA country perspective in exploring the links between hospital pharmacies and pharmaceutical industry: a case study applicationpor
dc.typearticleen_US
dc.publicationstatusPublicadopor
dc.peerreviewedyespor
dc.relation.publisherversionThe definitive version is available at: http://dx.doi.org/10.4172/2167-7689.S11-001por
dc.journalPharmaceutical Regulatory Affairspor
dc.distributionInternacionalpor
degois.publication.titlePharmaceutical Regulatory Affairspor
dc.date.updated2017-07-12T11:17:39Z-
dc.identifier.doi10.4172/2167-7689.S11-001-
Aparece nas coleções:BRU-RI - Artigos em revistas científicas internacionais com arbitragem científica

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
A Country Perspective in Exploring the links between Hospital Pharmacies and Pharmaceutical Industry.pdf1,12 MBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpaceOrkut
Formato BibTex mendeley Endnote Logotipo do DeGóis Logotipo do Orcid 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.